BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

4:47 PM
Mar 07, 2007
 |  BC Extra  |  Top Story

Tercica up on Insmed settlement

TRCA gained $1 (20%) to $5.88 on Wednesday after it and INSM announced late Tuesday that they have agreed to settle all outstanding litigation, including patent infringement lawsuits brought by TRCA and Genentech (DNA) against INSM for its iPlex mecasermin rinfibate. INSM said on Wednesday that it is restructuring and reducing its 150-person workforce by about 34%, which includes the elimination...

Read the full 295 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >